OVERVIEW: The Merck Company Foundation’s U.S.-based grantmaking is focused on cancer, hepatitis C, diabetes and HIV/AIDS.
IP TAKE: With a couple of major programs coming to their respective conclusions, the direction of Merck’s giving is in a bit of flux as to the funding directions it will take in the near future.
PROFILE: The Merck Company Foundation invests in projects intended to enhance health, education and community well-being, both in the United States and abroad. Stateside, the foundation zeroes in on cancer, diabetes, hepatitis C and HIV/AIDS. The foundation's stated goal is to "improve health care quality and health system capacity as well as increase access to care for underserved populations." In particular it focuses on organizations dedicated to the delivery of health care, though it offers support for biomedical research separately.
Much of the foundation's funding does to existing programs, such as the Alliance to Advance Patient-Centered Cancer Care and the China-MSD HIV/AIDS Partnership. However, it does have an open application system, and appears to accept proposals year round. In addition to the four diseases highlighted by the foundation, it also supports work on asthma through the Merck Childhood Asthma Network, so there may be possibilities for organizations working in other areas as well.
The foundation offers grants to organizations working nationally and internationally, but in the US it focuses especially on California, Delaware, Illinois, Massachusetts, Maryland, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, Texas, Virginia, Wyoming and the District of Columbia.
Separately from the foundation, Merck also supports medical research through its Investigator Studies Program, which focuses primarily on drug trials.